Continuing Medical Education
Stay up to date on the latest trends in eczema patient care by signing up for continuing medical education courses and activities through the National Eczema Association.
Register for a CME activity related to eczema care
The National Eczema Association (NEA) partners with accredited continuing medical education (CME) companies to offer online and in-person activities for healthcare providers with a focus on eczema care. Our goal is to provide valuable patient resources to healthcare providers, as well as share the lived experience of eczema to help improve overall care outcomes. We strive to provide the most current and meaningful information to improve eczema care for all types of providers — from specialists and primary care providers to nurse practitioners and pharmacists. Explore our latest offerings below. New opportunities are added regularly.
Current continuing education (CME/CE) activities
Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective
This activity is for: Pharmacists
The National Eczema Association partnered with Pharmacy Times to create an educational activity designed to enhance pharmacists’ ability to optimize skincare and outcomes of atopic dermatitis through OTC options. The discussion also features the perspective of a caregiver of a patient living with atopic dermatitis who will provide additional insight into challenges faced with atopic dermatitis treatment.
This activity expires July 24, 2025.
Conversations in Primary Care 2025
This activity is for: Primary care physicians, nurse practitioners (NPs), and physician associates (PAs)
The National Eczema Association partnered with the National Association for Continuing Education (NACE) on a new educational activity to improve providers’ knowledge, competence, and performance in diagnosing and managing atopic dermatitis (AD) in the primary care setting. The program features expert-led, case-based discussions on the assessment, treatment, and long-term management of AD, with a focus on emerging therapies, patient communication, and reducing barriers to care.
This activity expires July 26, 2025
Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis
This activity is for: Dermatologists, allergist/immunologists, nurse practitioners (NPs), and physician associates (PAs) practicing in dermatology and allergy
The National Eczema Association partnered with Clinical Education Alliance (Clinical Care Options and Practicing Clinicians Exchange) on a new educational activity to improve providers’ knowledge, competence, and performance in managing advanced therapies for patients with moderate to severe atopic dermatitis. The program features expert-led, case-based discussions on the role of interleukin-13 (IL-13) in AD pathophysiology and the clinical application of IL-13 inhibitors.
Taking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
This activity is for: Primary care physicians, nurse practitioners (NPs), and physician associates (PAs) who manage children with AD.
The National Eczema Association partnered with Clinical Education Alliance (Clinical Care Options and Practicing Clinicians Exchange) on a new educational activity to improve providers’ knowledge, competence, and performance in diagnosing and managing moderate to severe atopic dermatitis (AD) in pediatric patients within the primary care setting. The program features an expert-led, case-based webcast presentation focused on systemic therapies and the use of patient- and caregiver-reported outcomes to support person-centered care and improve long-term outcomes.
This activity expires on March 6, 2026
Recently expired education activities
The below activities are no longer available for CME/CE credit but may be accessed for their available content and resources.
Talking with your Patients about JAK Inhibitors for Atopic Dermatitis
The Society of Dermatology Nurse Practitioners, Skin of Color Society, National Eczema Association and Medscape Education partnered to create an educational activity on the risks and benefits of Janus kinase (JAK) inhibitors for patients with moderate-to-severe atopic dermatitis. This activity is intended for dermatologists, allergists, nurse practitioners and physician assistants in dermatology and allergy/immunology.
Clearing the Way for Pediatric Patients of All Races With Moderate to Severe Atopic Dermatitis: Expert Perspectives on Identifying and Assessing Disease Severity and Implementing Targeted Treatment
The National Eczema Association partnered with PeerView Institute for Medical Education to create an educational activity on the identification and assessment of atopic dermatitis severity in children and practical strategies regarding the integration of targeted biologic therapy for pediatric patients with moderate to severe atopic dermatitis.
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Diseases: Addressing Shared Pathophysiology with JAK Inhibitors
The National Eczema Association partnered with PeerView Institute for Medical Education to create an educational activity on the interdisciplinary approaches to the management of immune-mediated inflammatory diseases and addressing shared pathophysiology with JAK inhibitors.
Atopic Dermatitis: Practice Clinician Decision-Making in Virtual Patient Cases
The Society of Dermatology Nurse Practitioners, Skin of Color Society, National Eczema Association, and Medscape Education partnered to create an educational activity to help providers offer individualized evidence-based treatment strategies for patients with moderate to severe atopic dermatitis. This activity is intended for dermatologists, allergists, nurse practitioners and physician assistants in dermatology and allergy/immunology.
Adjunctive Therapies in Atopic Dermatitis: Understanding the Role of the Skin Barrier and Microbiome in Disease Management
The National Eczema Association partnered with Pharmacy Times to create an educational activity designed to enhance pharmacists’ ability to optimize skincare and outcomes of atopic dermatitis through OTC options. This webinar will outline the importance of daily skincare practices and counseling points pharmacists and pharmacy technicians can share with patients about the use of OTC skincare products and moisturizers in improving the skin barrier and reducing symptoms associated with atopic dermatitis.
